Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer.

Autor: Luhn P; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Chui SY; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Hsieh AF; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Yi J; Genesis Research Group, 5 Marine View Plaza, Hoboken, NJ 07030, USA., Mecke A; F. Hoffmann-La Roche, 4 Oncology, Grenzacherstrasse 124, 4070 Basel, Switzerland., Bajaj PS; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Hasnain W; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Falgas A; F. Hoffmann-La Roche, 4 Oncology, Grenzacherstrasse 124, 4070 Basel, Switzerland., Ton TG; Genentech, Inc., 1 DNA Way, MS 35-6i, South San Francisco, CA 94080, USA., Kurian AW; Departments of Medicine (Oncology) & of Health Research & Policy, Women's Clinical Cancer Genetics Program, Stanford University School of Medicine HRP Redwood Building, Room T254A, 150 Governor's Lane, Stanford, CA 94305, USA.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2019 Oct; Vol. 8 (14), pp. 1173-1185. Date of Electronic Publication: 2019 Aug 09.

Vulnerability to functional decline is associated with noncardiovascular cause of 90-day readmission in hospitalized patients with heart failure.

Autor: Trochez RJ; Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Barrett JB; Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Shi Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Schildcrout JS; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rick C;  Department of Medicine, Division of Geriatric Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Nair D; Department of Medicine, Division of Nephrology & Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Welch SA; Department of Physical Medicine & Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Veterans Affairs, Geriatric Research Education and Clinical Center(GRECC), Tennessee Valley Healthcare System, Nashville, Tennessee, USA., Kumar AA; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Bell SP; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kripalani S; Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Section of Hospital Medicine, Department of Medicine, Division of General Internal Medicine & Public Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Publikováno v: Journal of hospital medicine [J Hosp Med] 2024 May; Vol. 19 (5), pp. 386-393. Date of Electronic Publication: 2024 Feb 24.

Health outcomes after myocardial infarction: A population study of 56 million people in England.

Autor: Hall, Marlous^1,2 (AUTHOR) m.s.hall@leeds.ac.uk, Smith, Lesley³ (AUTHOR), Wu, Jianhua^2,4 (AUTHOR), Hayward, Chris^1,2 (AUTHOR), Batty, Jonathan A.^1,2 (AUTHOR), Lambert, Paul C.^5,6 (AUTHOR), Hemingway, Harry^7,8,9,10 (AUTHOR), Gale, Chris P.^1,2,11 (AUTHOR)

Publikováno v: PLoS Medicine. 2/15/2024, Vol. 21 Issue 2, p1-26. 26p.

Sex Differences in the Rate, Timing, and Principal Diagnoses of 30-Day Readmissions in Younger Patients with Acute Myocardial Infarction.

Autor: Dreyer RP; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted. rachel.dreyer@yale.edu., Ranasinghe I; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Wang Y; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Dharmarajan K; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Murugiah K; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Nuti SV; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Hsieh AF; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Spertus JA; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted., Krumholz HM; From the Center for Outcomes Research and Evaluation (CORE), Yale-New Haven Hospital, New Haven, CT (R.P.D., I.R., Y.W., K.D., K.M., S.V.N., A.F.H., H.M.K.); Section of Cardiovascular Medicine (R.P.D., I.R., Y.W., K.D., S.V.N., H.M.K.) and the Robert Wood Johnson Foundation Clinical Scholars Program (H.M.K.), New Haven, CT; Discipline of Medicine, The Queen Elizabeth Hospital, University of Adelaide, Adelaide SA (I.R.); Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, Kansas City, MO (J.A.S.); and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). Dr Ranasinghe was affiliated with the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Section of Cardiovascular Medicine, New Haven, CT during the time the work was conducted.

Publikováno v: Circulation [Circulation] 2015 Jul 21; Vol. 132 (3), pp. 158-66. Date of Electronic Publication: 2015 Jun 17.

Screening for frequent hospitalization risk among community-dwelling older adult between 2016 and 2023: machine learning-driven item selection, scoring system development, and prospective validation.

Autor: Leung, Eman, Guan, Jingjing, Zhang, Qingpeng, Ching, Chun Cheung, Yee, Hiliary, Liu, Yilin, Ng, Hang Sau, Xu, Richard, Tsang, Hector Wing Hong, Lee, Albert, Chen, Frank Youhua

Publikováno v: Frontiers in Public Health; 2024, p1-13, 13p